alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Defense

###### Department of the Army, Corps of Engineers

# AGENCY:

Department of the Army; Corps of Engineers, DoD.

# ACTION:

Notice; withdrawal. 

# SUMMARY:

                        A Notice of Intent To Prepare a Draft Programmatic Environmental Impact Statement (DPEIS) for the Onondaga Lake Watershed Management Plan (OLWMP), Feasibility Study, City of Syracuse, Onondaga County, Central New York State, and Onondaga Nation was published in the                         **Federal Register**                         on April 1, 2005 (70 FR 16807). Subsequent to the Notice of Intent, the project scope and funding was significantly reduced and modified and a decision made to terminate the EIS process. An Onondaga Lake Watershed Progress Assessment and Actions Strategies report is being prepared over the next two years and will be available to agencies, interests, and the public in 2009.                    

# ADDRESSES:

Correspondence should be addressed to: Mr. Tod Smith, U.S. Army Corps of Engineers, Buffalo District, Environmental Analyses Section, 1776 Niagara Street, Buffalo, NY 14207-3199.

# FOR FURTHER INFORMATION CONTACT:

                        Mr. Tod Smith, telephone at 716-879-4175, e-mail at                         *tod.d.smith@usace.army.mil.*

# SUPPLEMENTARY INFORMATION:

None.

Dated: September 4, 2007.

John S. Hurley,

Lieutenant Colonel, Corps of Engineers, District Commander.

[FR Doc. 07-4554 Filed 9-13-07; 8:45 am]

BILLING CODE 3710-GP-M
1210-AB32-2-1228.html[7/24/2015 8:47:40 PM]

PUBLIC SUBMISSION

As of: July 16, 2015

Received: July 09, 2015

Status: Pending_Post

Tracking No. 1jz-8jvt-f1n9

Comments Due: July 21, 2015

Submission Type: Web

Docket: EBSA-2010-0050

Definition of the Term ‘‘Fiduciary’’; Conflict of Interest Rule—Retirement Investment Advice; Notice of

 proposed rulemaking and withdrawal of previous proposed rule.

Comment On: EBSA-2010-0050-0205

Definition of Fiduciary; Conflict of Interest Rule-Retirement Investment Advice and Related Proposed

 Prohibited Transaction Exemptions; Hearing and Comment Period Extension

Document: EBSA-2010-0050-DRAFT-1723

Comment on FR Doc # 2015-14921

Submitter Information

Name: Anonymous Anonymous

General Comment

My husband and I have spent many years planning and preparing for retirement. Our 401K and IRA accounts

 can be managed just fine without further government interference. Leave people to be adults and manage their

 own affairs. Given responsibility people rise to the occasion and care for themselves and their loved ones.
EXHIBIT 32
                                   ----------


                CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
                       AS ADOPTED PURSUANT TO SECTION 906
                        OF THE SARBANES-OXLEY ACT OF 2002



        In connection with the Quarterly Report of Realmark Property Investors
Limited Partnership - II (the "Partnership") on Form 10-Q for the period ending
June 30, 2005 as filed with the Securities and Exchange Commission on the date
hereof (the "Report"), I, Joseph M. Jayson, Individual General Partner and
Principal Financial Officer, certify, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the
best of my knowledge:

        (1)       The Report fully complies with the requirements of Section
                  13(a) or 15(d) of the Securities and Exchange Act of 1934; and

        (2)       The information contained in the Report fairly presents, in
                  all material respects, the financial condition and result of
                  the operations of the Partnership.


              August 15, 2005                   /s/ Joseph M. Jayson
              ---------------                   ------------------------------
                  Date                          Joseph M. Jayson,
                                                Individual General Partner and
                                                Principal Financial Officer
BEFORE THE OHIO EPA

- - - IN RE: : : Infrastructure State Implementation : Plan :

- - - Public Hearing before Moderator Mary McCarron, taken at the Ohio Environmental Protection Agency, 50 West Town Street, 6th Floor Conference Room, Columbus, Ohio at 1:30 p.m. on Friday, December 21, 2012.

- - -**P-R-O-C-E-E-D-I-N-G-S**

- - - MODERATOR McCARRON: My name is Mary McCarron. I am the public involvement manager for the Ohio Environmental Protection Agency's Public Interest Center. I will be presiding over today's public hearing.

The purpose of the hearing today is to obtain comments from any interested person regarding Ohio EPA's proposed action.

The State of Ohio is submitting to U.S. EPA the Infrastructure State Implementation Plan for the state of Ohio.

All interested persons are entitled to attend or be represented and to present oral and/or written comments concerning the proposed action. All written and oral comments received as part of the official record will be considered by the Director of Ohio EPA.

To be included in the official record, written comments must be received by Ohio EPA by close of business today, December 21, 2012.

There is no one present to submit testimony, so we will go off the record for 30 2

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24minutes. (Break taken for until 2 o'clock p.m.) MODERATOR McCARRON: Seeing no requests for testimony, I remind you that written comments can be submitted through 5 o'clock today.

Thank you for attending. The time is now 2 o'clock, and this hearing is adjourned.

(Thereupon, at 2:00 p.m. on Friday, December 21, 2012, the public hearing was adjourned.)

- - - 3

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24**C E R T I F I C A T E**

- - - STATE OF OHIO : SS: COUNTY OF FRANKLIN :

I, Jennifer L. Parish, Registered Professional Reporter and Notary Public in the State of Ohio, do hereby certify that the foregoing is a true, correct, and complete transcript of the proceedings in the matter before the Ohio EPA as reported by me in stenotype and transcribed from my stenographic notes.

DATED this 27th day of December, 2012.

_______________________ JENNIFER L. PARISH, RPR NOTARY PUBLIC-STATE OF OHIO My Commission Expires: November 23, 2014. 4

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
Editorial Note on Part 40
Editorial Note: Nomenclature changes to part 40 appear at 73 FR 33329, June 12, 2008.

§ 40.137 On what basis does the MRO verify test results involving marijuana, cocaine, amphetamines, semi-synthetic opioids, or PCP? ( a ) As the MRO, you must verify a confirmed positive test result for marijuana, cocaine, amphetamines, semi-synthetic opioids (*i.e.,* hydrocodone, hydromorphone, oxycodone, and oxymorphone), and/or PCP unless the employee presents a legitimate medical explanation for the presence of the drug(s)/metabolite(s) in his or her system. In determining whether an employee's legally valid prescription consistent with the Controlled Substances Act for a substance in these categories constitutes a legitimate medical explanation, you must not question whether the prescribing physician should have prescribed the substance.
( b ) You must offer the employee an opportunity to present a legitimate medical explanation in all cases.
( c ) The employee has the burden of proof that a legitimate medical explanation exists. The employee must present information meeting this burden at the time of the verification interview. As the MRO, you have discretion to extend the time available to the employee for this purpose for up to five days before verifying the test result, if you determine that there is a reasonable basis to believe that the employee will be able to produce relevant evidence concerning a legitimate medical explanation within that time.
( d ) If you determine that there is a legitimate medical explanation, you must verify the test result as negative. Otherwise, you must verify the test result as positive.
( e ) In determining whether a legitimate medical explanation exists, you may consider the employee's use of a medication from a foreign country. You must exercise your professional judgment consistently with the following principles: ( 1 ) There can be a legitimate medical explanation only with respect to a substance that is obtained legally in a foreign country.
( 2 ) There can be a legitimate medical explanation only with respect to a substance that has a legitimate medical use. Use of a drug of abuse (*e.g.,* heroin, PCP, marijuana) or any other substance (see § 40.151(f) and (g)) that cannot be viewed as having a legitimate medical use can never be the basis for a legitimate medical explanation, even if the substance is obtained legally in a foreign country.
( 3 ) Use of the substance can form the basis of a legitimate medical explanation only if it is used consistently with its proper and intended medical purpose.
( 4 ) Even if you find that there is a legitimate medical explanation under this paragraph (e) and verify a test negative, you may have a responsibility to raise fitness-for-duty considerations with the employer (see § 40.327).
[65 FR 79526, Dec. 19, 2000, as amended at 82 FR 52245, Nov. 13, 2017]
V

107TH CONGRESS

1ST SESSION H. R. 935

To authorize the Secretary of Transportation to issue a certificate of documentation with appropriate endorsement for employment in the coastwise

trade and fisheries for the vessel TOKEENA.

IN THE HOUSE OF REPRESENTATIVES

MARCH 7, 2001

Mr. GRAHAM introduced the following bill; which was referred to the

Committee on Transportation and Infrastructure

A BILL

To authorize the Secretary of Transportation to issue a

certificate of documentation with appropriate endorsement for employment in the coastwise trade and fisheries

for the vessel TOKEENA.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 That notwithstanding section 27 of the Merchant Marine

4 Act, 1920 (46 App. U.S.C. 883), section 8 of the Act of

5 June 19, 1886 (46 App. U.S.C. 289), and sections 12106

6 and 12108 of title 46, United States Code, the Secretary

7 of Transportation may issue a certificate of documentation

8 with appropriate endorsement for employment in the
2

•HR 935 IH

1 coastwise trade and fisheries for the vessel TOKEENA

2 (State of North Carolina registration number N6083BN).

Æ
**Exhibit 23-1**

 

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

 

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-57640, 333-84446 and 333-108546), onForm S-4 (No. 333-122704), and on Form S-8 (No. 333-49780, 333-61390 and 333-127377) of Exelon Corporation of our report dated February 15, 2006, relating to the financial statements, financial statement schedule, management’s assessment of theeffectiveness of internal control over financial reporting and the effectiveness of internal control over financial reporting, which appears in this Form 10-K. 

 

 

 

 

 

PricewaterhouseCoopers LLP 

Chicago, Illinois 

February 15, 2006
1210-AB32-2-1645.html[7/26/2015 9:30:28 PM]

PUBLIC SUBMISSION

As of: July 16, 2015

Received: July 12, 2015

Status: Pending_Post

Tracking No. 1jz-8jy2-23t8

Comments Due: July 21, 2015

Submission Type: Web

Docket: EBSA-2010-0050

Definition of the Term ‘‘Fiduciary’’; Conflict of Interest Rule—Retirement Investment Advice; Notice of

 proposed rulemaking and withdrawal of previous proposed rule.

Comment On: EBSA-2010-0050-0205

Definition of Fiduciary; Conflict of Interest Rule-Retirement Investment Advice and Related Proposed

 Prohibited Transaction Exemptions; Hearing and Comment Period Extension

Document: EBSA-2010-0050-DRAFT-2143

Comment on FR Doc # 2015-14921

Submitter Information

Name: Randy Anonymous

General Comment

I wish to maintain the freedom to manage my own investments without restrictive interference from some

 government agency. The government intervention into yet another aspect of personal choice is extremely

 disturbing and threatens our liberties once more. Leave our retirement planning alone since you have proven

 with social security, Fanni Mae, Freddie Mac, postal service that you clearly do not know what you are doing. I

 can manage my affairs much better than you!
<TABLE> <S> <C>


<ARTICLE>                     5
<LEGEND>
     (Replace this text with the legend)
</LEGEND>
<CIK>                         0000707853
<NAME>                        Rancon Realty Fund III
<MULTIPLIER>                                   1,000
<CURRENCY>                                     U.S. Dollars
       
<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                              DEC-31-1997
<PERIOD-START>                                 JAN-01-1997
<PERIOD-END>                                   SEP-30-1997
<EXCHANGE-RATE>                                1.000
<CASH>                                         1,268
<SECURITIES>                                       0
<RECEIVABLES>                                      1
<ALLOWANCES>                                       0
<INVENTORY>                                        0
<CURRENT-ASSETS>                               1,269
<PP&E>                                         3,111
<DEPRECIATION>                                   602
<TOTAL-ASSETS>                                 3,812
<CURRENT-LIABILITIES>                             40
<BONDS>                                            0
<PREFERRED-MANDATORY>                              0
<PREFERRED>                                        0
<COMMON>                                           0
<OTHER-SE>                                     3,763
<TOTAL-LIABILITY-AND-EQUITY>                   3,812
<SALES>                                            0
<TOTAL-REVENUES>                                 179
<CGS>                                              0
<TOTAL-COSTS>                                      0
<OTHER-EXPENSES>                               1,608
<LOSS-PROVISION>                                   0
<INTEREST-EXPENSE>                                 0
<INCOME-PRETAX>                              (1,429)
<INCOME-TAX>                                       0
<INCOME-CONTINUING>                          (1,429)
<DISCONTINUED>                                     0
<EXTRAORDINARY>                                    0
<CHANGES>                                          0
<NET-INCOME>                                 (1,429)
<EPS-PRIMARY>                                (37.36)
<EPS-DILUTED>                                (37.36)
        


</TABLE>
###### Editorial Note on Part 376

#### Editorial Note:

Nomenclature changes to part 376 appear at 66 FR 49871, Oct. 1, 2001.

#### § 376.26 Exemption for leases between authorized carriers and their agents.

The leasing regulations set forth in § 376.12(e) through (l) do not apply to leases between authorized carriers and their agents.

[47 FR 28398, June 30, 1982, as amended at 62 FR 15424, Apr. 1, 1997]
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### National Institutes of Health

Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting.

The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

*Name of Committee:*                         National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Sexually Transmitted Infections (STI) Cooperative Research Centers (CRC): Vaccine Development (U01 Clinical Trial Not Allowed).                    

*Date:*                         September 21, 2023.                    

*Time:*                         10:00 a.m. to 6:00 p.m.                    

*Agenda:*                         To review and evaluate grant applications.                    

*Place:*                         National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3F52A, Rockville, MD 20892 (Virtual Meeting).                    

*Contact Person:*                         Shilpakala Ketha, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities,  National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3F52A, Rockville, MD 20852, (301) 761-6821,                         *shilpa.ketha@nih.gov.*

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS)

Dated: August 15, 2023.

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory Committee Policy.

[FR Doc. 2023-17891 Filed 8-18-23; 8:45 am]

BILLING CODE 4140-01-P
##### 



Exhibit 32.B Certification Pursuant to
18 U.S.C. Section 1350,
as Adopted Pursuant to Section 906
of the Sarbanes-Oxley Act of 2002 In
connection with the Annual Report on Form 10-K/A for the period ending December 31, 2004, of
El Paso CGP Company (the Company) as filed with the Securities and Exchange Commission on the
date hereof (the Report), I, D. Dwight Scott, Executive Vice President and Chief Financial
Officer, certify (i) that the Report fully complies with the requirements of Section 13(a) or 15(d)
of the Securities Exchange Act of 1934, as amended, and (ii) that the information contained in the
Report fairly presents, in all material respects, the financial condition and results of operations
of the Company. /s/ D. Dwight ScottD. Dwight ScottExecutive Vice President andChief Financial Officer
(Principal Financial Officer) June 20, 2005 A signed original of this written statement required by Section 906 has been provided to El Paso
CGP Company and will be retained by El Paso CGP Company and furnished to the Securities and
Exchange Commission or its staff upon request.
#### Austin S. Cushman, Appellant, v. Henry A. Mott, Respondent.

Judgment affirmed, with costs.
**REGULATORY EVALUATION**

**Directorate Identifier:** 2011

- NM

- 110

- AD

**Executive Order 12866:** Could the AD be considered a “significant regulatory action”? YES ( ) explain NO (X) **DOT Regulatory Policies and Procedures:** Is the AD significant? YES ( ) explain NO (X) **Regulatory Flexibility Act:** Will the AD have a significant economic impact on a substantial number of small entities? YES ( ) explain NO (X) **Intrastate Aviation in Alaska:** This AD could affect intrastate aviation in Alaska. I s it appropriate t o include specific requirements for aircraft operated in Alaska, where aviation might be the only mode of transportation? YES ( ) explain NO (X)
§ 271.223 Internal assessment process. ( a ) An RRP plan shall describe the railroad's processes for conducting an internal assessment of its RRP pursuant to subpart E of this part. At a minimum, this description shall contain the railroad's processes used to: ( 1 ) Conduct an internal assessment of its RRP;
( 2 ) Internally report the results of its internal assessment to railroad senior management; and
( 3 ) Develop improvement plans, including developing and monitoring recommended improvements (including any necessary revisions or updates to the RRP plan) for fully implementing the railroad's RRP, complying with the implemented elements of the RRP plan, or achieving the goals identified in the railroad's RRP plan pursuant to § 271.203(c).
( b ) [Reserved]
1210-AB32-2-1364.html[7/26/2015 2:34:37 PM]

PUBLIC SUBMISSION

As of: July 16, 2015

Received: July 09, 2015

Status: Pending_Post

Tracking No. 1jz-8jvz-er4k

Comments Due: July 21, 2015

Submission Type: Web

Docket: EBSA-2010-0050

Definition of the Term ‘‘Fiduciary’’; Conflict of Interest Rule—Retirement Investment Advice; Notice of

 proposed rulemaking and withdrawal of previous proposed rule.

Comment On: EBSA-2010-0050-0205

Definition of Fiduciary; Conflict of Interest Rule-Retirement Investment Advice and Related Proposed

 Prohibited Transaction Exemptions; Hearing and Comment Period Extension

Document: EBSA-2010-0050-DRAFT-1860

Comment on FR Doc # 2015-14921

Submitter Information

Name: Anonymous Anonymous

Organization: freedom works

General Comment

Keep your hands off my retirement money!